Zhang, L., Xu, Z., Mak, J. W. Y., Chow, K. M., Lui, G., Li, T. C. M., . . . Ng, S. C. (2022). Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study. Journal of Gastroenterology and Hepatology, 37(5), 823-831. https://doi.org/10.1111/jgh.15796
Chicago Style (17th ed.) CitationZhang, Lin, et al. "Gut Microbiota‐derived Synbiotic Formula (SIM01) as a Novel Adjuvant Therapy for COVID‐19: An Open‐label Pilot Study." Journal of Gastroenterology and Hepatology 37, no. 5 (2022): 823-831. https://doi.org/10.1111/jgh.15796.
MLA (9th ed.) CitationZhang, Lin, et al. "Gut Microbiota‐derived Synbiotic Formula (SIM01) as a Novel Adjuvant Therapy for COVID‐19: An Open‐label Pilot Study." Journal of Gastroenterology and Hepatology, vol. 37, no. 5, 2022, pp. 823-831, https://doi.org/10.1111/jgh.15796.